PRESS RELEASE published on 07/23/2024 at 10:06, 1 year 9 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Sphene Capital GmbH updates research report on Ikonisys SA, adjusting price target to EUR 5.50 from EUR 6.30. Company's 2023 financial figures below expectations, 2024 forecasts driven by collaborations Financial Figures Ikonisys SA Price Target Collaborations Sphene Capital GmbH
BRIEF published on 07/18/2024 at 19:10, 1 year 9 months ago Ikonisys Completes €250k Capital Increase Via Private Placement Private Placement Capital Increase Financial Resources Cancer Detection Ikonisys
BRIEF published on 07/18/2024 at 19:10, 1 year 9 months ago Ikonisys finalise une augmentation de capital de 250 000 € via un placement privé Placement Privé Augmentation De Capital Ressources Financières Détection Du Cancer Ikonisys
PRESS RELEASE published on 07/18/2024 at 19:05, 1 year 9 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Ikonisys completed a €250k capital increase through a private placement with CC Holding Srl to strengthen financial resources for commercial development Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
PRESS RELEASE published on 07/18/2024 at 19:05, 1 year 9 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Ikonisys finalise une augmentation de capital de 250 K€ via un placement privé avec CC Holding Srl pour renforcer ses ressources financières et son développement commercial Placement Privé Augmentation De Capital Développement Commercial Ikonisys CC Holding Srl
BRIEF published on 06/11/2024 at 18:35, 1 year 10 months ago Ikonisys and Ulisse Biomed enter into a strategic partnership for cancer diagnosis Innovation Biotechnology Partnership Diagnostic Cancer
BRIEF published on 06/11/2024 at 18:35, 1 year 10 months ago Ikonisys et Ulisse Biomed nouent un partenariat stratégique pour le diagnostic du cancer Innovation Biotechnologie Partenariat Diagnostic Cancer
PRESS RELEASE published on 06/11/2024 at 18:30, 1 year 10 months ago Inside Information / Other news releases Ikonisys and Ulisse Biomed announce strategic partnership to enhance cancer diagnostics through technical and commercial collaboration, aiming to provide innovative solutions and maximize market penetration Innovation Strategic Partnership Cancer Diagnostics Ikonisys Ulisse Biomed
PRESS RELEASE published on 06/11/2024 at 18:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Ikonisys et Ulisse Biomed annoncent un partenariat stratégique pour soutenir l'innovation dans le domaine du diagnostic du cancer Innovation Partenariat Stratégique Ikonisys Diagnostic Du Cancer Ulisse Biomed
BRIEF published on 06/03/2024 at 21:04, 1 year 11 months ago Ikonisys finalise une augmentation de capital pour stimuler son expansion commerciale Placement Privé Augmentation De Capital Expansion Commerciale Ikonisys Intégration Hospitex
Published on 05/09/2026 at 01:30, 1 day 15 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 16 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 34 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 2 hours 39 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 4 hours 54 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 21 hours 34 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 20 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 2 days 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 21 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 21 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
